Benzinga | Jul 30, 2020 10:27AM EDT

SunTrust Robinson Humphrey Maintains Buy on Amedisys, Raises Price Target to $270

SunTrust Robinson Humphrey maintains Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $260 to $270.